MiR-221 Promotes Hepatocellular Carcinoma Cells Migration via Targeting PHF2

被引:33
作者
Fu, Yi [1 ]
Liu, Mingyan [2 ]
Li, Fengxia [2 ]
Qian, Li [2 ]
Zhang, Ping [3 ]
Lv, Fengwei [2 ]
Cheng, Wenting [2 ]
Hou, Ruixing [3 ]
机构
[1] Soochow Univ, Sch Biol & Basic Med Sci, Dept Human Anat Histol & Embryol, Suzhou 215007, Peoples R China
[2] Yangzhou Univ, Sch Med, Yangzhou 225001, Jiangsu, Peoples R China
[3] Soochow Univ, Ruihua Affiliated Hosp, Inst Hand Surg, Suzhou 215007, Peoples R China
关键词
D O I
10.1155/2019/4371405
中图分类号
Q81 [生物工程学(生物技术)]; Q93 [微生物学];
学科分类号
071005 ; 0836 ; 090102 ; 100705 ;
摘要
MicroRNAs (MiRNAs), which regulate the gene expression leading to translational inhibition or mRNA degradation, are involved in carcinogenesis and tumor progression. Previous studies have demonstrated that miR-221 was one of the most consistent overexpressed miRNAs in several types of cancer. However, the role of miR-221 in human liver cancer progression is not yet fully elucidated. Levels of miR-221 and plant homeodomain finger 2 (PHF2) expressions in human hepatocellular carcinoma (HCC) tissues and cell lines were detected using western blotting and quantitative real-time PCR (qRT-PCR). Cell migration was studied using the transwell assays. A dual-luciferase reporter system was used to validate the target gene of miR-221. The results indicated that miR-221 promoted HCC cell migration. By performing subsequent systematic bioinformatic analyses, we found PHF2 was the target gene of miR-221 and the direct binding relationship was further validated by dual-luciferase reporter assay. In addition, lower expression of PHF2 promoted HCC cell migration and linked to worse overall survival in HCC patients. Finally, the negative correlation between miR-221 and PHF2 expression levels in HCC specimens was further confirmed. Taken together, our findings implied that miR-221 could be a potential candidate for the therapeutics of HCC metastasis.
引用
收藏
页数:11
相关论文
共 26 条
[1]   Diversifying microRNA sequence and function [J].
Ameres, Stefan L. ;
Zamore, Phillip D. .
NATURE REVIEWS MOLECULAR CELL BIOLOGY, 2013, 14 (08) :475-488
[2]  
[Anonymous], 2017, PLOS ONE, V12
[3]   MicroRNAs: Genomics, biogenesis, mechanism, and function (Reprinted from Cell, vol 116, pg 281-297, 2004) [J].
Bartel, David P. .
CELL, 2007, 131 (04) :11-29
[4]   Long-term prognostic impact of osteopontin and Dickkopf-related protein 1 in patients with hepatocellular carcinoma after hepatectomy [J].
Byeon, Hyerim ;
Lee, Seung Duk ;
Hong, Eun-Kyung ;
Lee, Dong Eun ;
Kim, Bo Hyun ;
Seo, Yunsung ;
Joo, Jungnam ;
Han, Sung-Sik ;
Kim, Seong Hoon ;
Park, Sang-Jae .
PATHOLOGY RESEARCH AND PRACTICE, 2018, 214 (06) :814-820
[5]   Cancer Statistics in China, 2015 [J].
Chen, Wanqing ;
Zheng, Rongshou ;
Baade, Peter D. ;
Zhang, Siwei ;
Zeng, Hongmei ;
Bray, Freddie ;
Jemal, Ahmedin ;
Yu, Xue Qin ;
He, Jie .
CA-A CANCER JOURNAL FOR CLINICIANS, 2016, 66 (02) :115-132
[6]   Hepatocellular carcinoma: Epidemiology and molecular carcinogenesis [J].
El-Serag, Hashem B. ;
Rudolph, Lenhard .
GASTROENTEROLOGY, 2007, 132 (07) :2557-2576
[7]   Tumor-Induced Osteoclast miRNA Changes as Regulators and Biomarkers of Osteolytic Bone Metastasis [J].
Ell, Brian ;
Mercatali, Laura ;
Ibrahim, Toni ;
Campbell, Neil ;
Schwarzenbach, Heidi ;
Pantel, Klaus ;
Amadori, Dino ;
Kang, Yibin .
CANCER CELL, 2013, 24 (04) :542-556
[8]   MiR-221 controls CDKN1C/p57 and CDKN1B/p27 expression in human hepatocellular carcinoma [J].
Fornari, F. ;
Gramantieri, L. ;
Ferracin, M. ;
Veronese, A. ;
Sabbioni, S. ;
Calin, G. A. ;
Grazi, G. L. ;
Giovannini, C. ;
Croce, C. M. ;
Bolondi, L. ;
Negrini, M. .
ONCOGENE, 2008, 27 (43) :5651-5661
[9]   miR221/222 in Cancer: Their Role in Tumor Progression and Response to Therapy [J].
Garofalo, M. ;
Quintavalle, C. ;
Romano, G. ;
Croce, C. M. ;
Condorelli, G. .
CURRENT MOLECULAR MEDICINE, 2012, 12 (01) :27-33
[10]   Prolonged mammosphere culture of MCF-7 cells induces an EMT and repression of the estrogen receptor by microRNAs [J].
Guttilla, I. K. ;
Phoenix, K. N. ;
Hong, X. ;
Tirnauer, J. S. ;
Claffey, K. P. ;
White, B. A. .
BREAST CANCER RESEARCH AND TREATMENT, 2012, 132 (01) :75-85